Le Lézard
Classified in: Health
Subjects: CCA, TDS, FVT

Tivity Health to Present at the 39th Annual J.P. Morgan Healthcare Conference


NASHVILLE, Tenn., Dec. 17, 2020 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ: TVTY) today announced that it will participate in the virtual 39th Annual J.P. Morgan Healthcare Conference, which will include a presentation by Richard Ashworth, President & Chief Executive Officer, followed by a question and answer session including Adam Holland, Chief Financial Officer, and Tommy Lewis, Chief Operating Officer, on Thursday, January 14, 2021 at 10:50 a.m. ET. A live audio-only webcast and replay of the event will be available on the "Investors" section of the Company's website, www.tivityhealth.com. Please go to the site at least 15 minutes prior to the discussion to download and install any necessary audio software.

About Tivity Health, Inc.
Tivity Health, Inc® (Nasdaq: TVTY) is a leading provider of healthy life-changing solutions, including SilverSneakers®, Prime® Fitness WholeHealth Living® and Wisely Welltm. We are actively addressing the social determinants of health, defined as the conditions in which we work, live and play. From improving health outcomes to reversing the narrative on inactivity, food insecurity, and social isolation and loneliness, we are making a difference and are transforming the way we do health. Learn more at TivityHealth.com.

 

SOURCE Tivity Health


These press releases may also interest you

at 03:05
The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer Patients
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK's National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to...

at 03:00
San Luis Obispo electrician answers 'Home or public EV charging, which is best?'
Charging an electric vehicle (EV) at home is certainly more convenient than using a public charging station, but what are the other benefits? Along with convenience, the...

at 02:15
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

at 01:00
Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders'...

More news about Health...


News published on and distributed by: